【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Disease Overview
06.1 Understanding the Disease
06.2 Pathophysiology
06.3 Epidemiology
06.4 Diagnosis
06.5 Staging
06.5.1 Staging: Colon Cancer
06.5.2 Staging: Rectal Cancer
06.6 Management
06.7 Economic Burden
07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.2.1 Colorectal Cancer Drugs Market in US
07.2.2 Colorectal Cancer Drugs Market in Germany
07.2.3 Colorectal Cancer Drugs Market in Spain
07.2.4 Colorectal Cancer Drugs Market in Japan
07.2.5 Colorectal Cancer Drugs Market in China
07.3 Five Forces Analysis
08.Market Segmentation by Type of Molecules
08.1 Small molecules
08.2 Biologics
09.Market Segmentation by Route of Administration
09.1 Oral
09.2 Parenteral
10.Geographical Segmentation
10.1 Colorectal Cancer Drugs Market in Americas
10.1.1 Market Size and Forecast
10.2 Colorectal Cancer Drugs Market in EMEA
10.2.1 Market Size and Forecast
10.3 Colorectal Cancer Drugs Market in APAC
10.3.1 Market Size and Forecast
11.Key Leading Countries
11.1 US
11.2 Japan
11.3 Germany
11.4 Spain
11.5 China
12.Buying Criteria
13.Market Growth Drivers
14.Drivers and their Impact
15.Market Challenges
16.Impact of Drivers and Challenges
17.Market Trends
18.Trends and their Impact
19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 Competitive Assessment of Top Drugs for Colorectal Cancer
19.2.2 F. Hoffmann-La Roche
19.2.3 Merck Serono
19.2.4 Bristol-Myers Squibb
19.2.5 Amgen
19.2.6 Sanofi
19.2.7 Bayer
19.3 Other and Future Prominent Vendors
20.Key Takeaways
21.Key Vendor Analysis
21.1 Amgen
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue 2013
21.1.4 Product Portfolio by Revenue 2013
21.1.5 Business Segmentation by Revenue 2012 and 2013
21.1.6 Geographical Segmentation by Revenue 2013
21.1.7 Business Strategy
21.1.8 Recent Developments
21.1.9 SWOT Analysis
21.2 Bayer
21.2.1 Key facts
21.2.2 Business overview
21.2.3 Business segmentation by revenue 2014
21.2.4 Business segmentation by revenue 2013 and 2014
21.2.5 Geographical segmentation by revenue 2014
21.2.6 Business strategy
21.2.7 Recent developments
21.2.8 SWOT analysis
21.3 Bristol-Myers Squibb Co.
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Key Product Offerings
21.3.4 Revenue by Geography
21.3.5 Business Strategy
21.3.6 Key Information
21.3.7 SWOT Analysis
21.4 F. Hoffmann-La Roche Ltd.
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation
21.4.4 Business Segmentation by Revenue 2012 and 2013
21.4.5 Sales by Geography
21.4.6 Business Strategy
21.4.7 Key Information
21.4.8 SWOT Analysis
21.5 Merck Serono
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Geographical Segmentation by Revenue 2013
21.5.4 Business Strategy
21.5.5 Recent Developments
21.5.6 SWOT Analysis
21.6 Sanofi SA
21.6.1 Key Facts
21.6.2 Business Description
21.6.3 Business Segmentation
21.6.4 Revenue by Business Segmentation
21.6.5 Revenue Comparison 2012 and 2013
21.6.6 Sales by Geography
21.6.7 Business Strategy
21.6.8 Key Developments
21.6.9 SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Drivers and Challenges of the Global Colorectal Cancer Drugs Market
Exhibit 3: Diagnosis of Colorectal Cancer
Exhibit 4: Management of Colorectal Cancer
Exhibit 5: A Snapshot of the Economic Burden of the Global Colorectal Cancer Drugs Market
Exhibit 6: Snapshot of the Global Colorectal Cancer Drugs Market
Exhibit 7: Global Colorectal Cancer Drugs Market 2014-2019 ($ millions)
Exhibit 8: Colorectal Cancer Drugs Market in US 2014-2019 ($ millions)
Exhibit 9: Colorectal Cancer Drugs Market in Germany 2014-2019 ($ millions)
Exhibit 10: Colorectal Cancer Drugs Market in Spain 2014-2019 ($ millions)
Exhibit 11: Colorectal Cancer Drugs Market in Japan 2014-2019 ($ millions)
Exhibit 12: Colorectal Cancer Drugs Market in China 2014-2019 ($ millions)
Exhibit 13: Segmentation of Global Colorectal Cancer Drugs Market by Type of Molecules
Exhibit 14: Segmentation of Global Colorectal Cancer Drugs Market by Type of Molecules, 2014
Exhibit 15: Segmentation of Global Colorectal Cancer Drugs Market by Route of Administration
Exhibit 16: Segmentation of Global Colorectal Cancer Drugs Market by Route of Administration, 2014
Exhibit 17: Global Colorectal Cancer Drugs Market by Geographical Segmentation 2014
Exhibit 18: Colorectal Cancer Drugs Market in Americas 2014-2019 ($ millions)
Exhibit 19: Colorectal Cancer Drugs Market in EMEA 2014-2019 ($ millions)
Exhibit 20: Colorectal Cancer Drugs Market in APAC 2014-2019 ($ millions)
Exhibit 21:
Exhibit 22: Drivers of the Global Colorectal Cancer Drugs Market
Exhibit 23: Challenges of the Global Colorectal Cancer Drugs Market
Exhibit 24: Trends of the Global Colorectal Cancer Drugs Market
Exhibit 25: YoY Growth Rate of the Major Colorectal Cancer Drugs 2010-2014 ($ millions)
Exhibit 26: F. Hoffmann-La Roche: Product Portfolio
Exhibit 27: Avastin: Global Revenue and YoY Growth Rate 2010-2014 ($ millions)
Exhibit 28: Avastin: Region-wise Revenues 2010-2014 ($ millions)
Exhibit 29: YoY Revenues and Growth Rate of Avastin in the US 2010-2014 ($ millions)
Exhibit 30: YoY Revenues and Growth Rate of Avastin in Europe 2010-2014 ($ millions)
Exhibit 31: YoY Revenues and Growth Rate of Avastin in Japan 2010-2014 ($ millions)
Exhibit 32: YoY International Revenues and Growth Rate of Avastin 2010-2014 (Except US, Europe, Japan) ($ millions)
Exhibit 33: Xeloda: Global Revenue and YoY Growth Rate 2010-2014 ($ millions)
Exhibit 34: Xeloda: Region-wise Revenues 2010-2014 ($ millions)
Exhibit 35: YoY Revenues and Growth Rate of Xeloda in the US ($ millions)
Exhibit 36: YoY Revenues and Growth Rate of Xeloda in Europe 2010-2014 ($ millions)
Exhibit 37: YoY Revenues and Growth Rate of Xeloda in Japan 2010-2014 ($ millions)
Exhibit 38: YoY International Revenues and Growth Rate of Xeloda (Except US, Europe, Japan) ($ millions)
Exhibit 39: Merck Serono: Product Portfolio
Exhibit 40: Erbitux: Revenue and YoY Growth Rate except US and Canada 2010-2014 ($ millions)
Exhibit 41: Erbitux: Region-wise Revenues 2012-2014 ($ millions)
Exhibit 42: Erbitux: Revenue and YoY Growth Rate in Europe 2012-2014 ($ millions)
Exhibit 43: Erbitux: Revenue and YoY Growth Rate in Emerging Markets 2012-2014 ($ millions)
Exhibit 44: Erbitux: Revenue and YoY Growth Rate in ROW 2012-2014 ($ millions)
Exhibit 45: Bristol-Myers Squibb: Product Portfolio
Exhibit 46: Erbitux: Revenue and YoY Growth Rate in US and Canada 2010-2014 ($ millions)
Exhibit 47: Amgen: Product Portfolio
Exhibit 50: Vectibix: Global Revenue and YoY Growth Rate 2010-2014 ($ millions)
Exhibit 51: Vectibix: Region-wise Revenues 2010-2014 ($ millions)
Exhibit 52: Sanofi: Product Portfolio
Exhibit 53: Eloxatin: Global Revenue and YoY Growth Rate 2010-2014 ($ millions)
Exhibit 54: Eloxatin: Region-wise Revenues 2010-2014 ($ millions)
Exhibit 55: YoY Revenues and Growth Rate of Eloxatin in the US ($ millions)
Exhibit 56: YoY Revenues and Growth Rate of Eloxatin in Europe ($ millions)
Exhibit 57: YoY Revenues and Growth Rate of Eloxatin in Emerging Markets ($ millions)
Exhibit 58: YoY Revenues and Growth Rate of Eloxatin in ROW 2010-2014 ($ millions)
Exhibit 59: Zaltrap: Global Revenue and YoY Growth Rate 2012-2014 ($ millions)
Exhibit 60: Zaltrap: Region-wise Revenue 2013-2014 ($ millions)
Exhibit 61: Bayer: Product Portfolio
Exhibit 62: Stivarga: Global Revenue and YoY Growth Rate 2012-2014 ($ millions)
Exhibit 63: Key Takeaways: Global Colorectal Cancer Drugs Market 2015-2019
Exhibit 64: Amgen: Business Segmentation by Revenue 2013
Exhibit 65: Amgen: Product Portfolio by Revenue 2013
Exhibit 66: Amgen: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 67: Amgen: Geographical Segmentation by Revenue 2013
Exhibit 68: Bayer: Business segmentation by revenue 2014
Exhibit 69: Bayer: Business segmentation by revenue 2013 and 2014 (US$ billion)
Exhibit 70: Bayer: Geographical segmentation by revenue 2014
Exhibit 71: Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
Exhibit 72: Bristol-Myers Squibb Co.: Revenue by Geographical Segmentation 2013
Exhibit 73: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 74: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 75: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 76: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 77: Merck Serono: Geographical Segmentation by Revenue 2013
Exhibit 78: Sanofi SA: Business Segmentation
Exhibit 79: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 80: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 81: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル：大腸癌治療薬の世界市場2015-2019■ 英文：Global Colorectal Cancer Drugs Market 2015-2019
■ 発行日：2015年6月17日
■ 調査会社：Technavio
■ 商品コード：IRTNTR6118
■ 調査対象地域：グローバル
- 欧州のNGS（次世代シークエンシング）サービス市場The NGS services market in Europe is expected to reach USD 1,152 million by 2020 from USD 444 million in 2015, at a CAGR of 21% from 2015 to 2020. The European NGS services market is segmented on the basis of technology, application, end user, disease type, and country. The European NGS services market is primarily driven by factors such as faster and cost-efficient sequencing; rising preference o …
- 麻酔深度モニタリングの世界市場予測（～2024年）“Increasing number of surgeries in the US to drive the overall growth of the US depth of anesthesia monitoring market” The US depth of anesthesia monitoring market is projected to grow from USD 141 million in 2018 to USD 170 million by 2024, at a CAGR of 3.2% during the forecast period. The increasing number of surgeries and rising patient volume in hospitals in the US are the major factors drivin …
- クラウドストレージゲートウェイの世界市場Today, most of the business enterprises running across the huge plethora various industries such as Banking, Financial Services and Insurance (BFSI), retail and consumer goods, manufacturing, healthcare and life sciences, research and education, high tech and electronics, media and entertainment and many others. These businesses are generating excess of data which can be counted as even Exabyte in …
- 世界の親水コロイド市場：ゼラチン、キサンタン、グアーなどHydrocolloid is large molecules that can form viscous liquid or gels when dispersed in water. They can perform wide range of functions such as thickening, stabilizing, and gelling agent in food industry. They can easily modify the properties of food products. Due to their functional properties and applications, the hydrocolloid is extensively used across the world. The global food hydrocolloid mar …
- 教室管理システムの世界市場2020-2024Global Classroom Management Systems Market 2020-2024 Technavio has been monitoring the global classroom management systems market and it is poised to grow by USD 8.82 bn during 2020-2024, progressing at a CAGR of 28% during the forecast period. Our reports on classroom management systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well …
- 商用車の世界市場2015-2022According to Stratistics MRC, the Global Commercial Vehicles market is accounted for $463.58 billion in 2015 and is expected to reach $699.97 billion by 2022 growing at a CAGR of 6.1%. In this modern era of Globalization the commercial transport is being enabled between cities, states and National Borders for trade activity. The growth in market and in country is reliable on level of transport and …
- Sodium percarbonateの世界市場Sodium percarbonate (CAS 15630-89-4) Market Research Report 2013 presents comprehensive data on Sodium percarbonate markets globally and regionally (Europe, Asia, North America etc.) The Sodium percarbonate (CAS 15630-89-4) Market Research Report 2013 includes Sodium percarbonate description, covers its application areas and related patterns. It overviews Sodium percarbonate market, names Sodium p …
- 世界の3Dプリンター用材料市場分析と予測The method to print an object layer by layer to create a three-dimensional object from a digital file with the use of a material is called 3D printing and the material used is called 3D printing material. The material used plays the key role in any 3D printing technology as 3D printed objects have the ability to be used practically. With the latest technologies and innovative materials, 3D printin …
- 食品用香料の世界市場：種類（チョコレート、バニラ、果物、ナッツ）、原料（天然香料、合成香料）、用途、地域別分析Flavors are used in a wide range of products that include bakery, snacks, confectionery, meat, poultry, and seafood. The food flavors market, by origin includes natural and synthetic flavors. The food flavors market is driven by changing consumer trends and food preferences. The food & beverage (F&B) processing industry also influences the food flavors market. F&B manufacturers widely use syntheti …
- 精密収穫の世界市場予測（～2023年）Precision harvesting market anticipated to grow at CAGR of 10.94% from 2018 to 2023The precision harvesting market was worth USD 10.4 billion in 2018 and is projected to reach USD 17.5 billion by 2023, at a CAGR of 10.94% during 2018–2023. The major factors driving the growth of the precision harvesting market are increasing farm mechanization in developing countries in Asia Pacific and Africa, in …
- Google IS BroadbandEverything broadband was supposed to do in 1999 terms (per endless, mind-numbing trade show panel discussions) seems to be offered by Google today including a range of video products, an emerging cloud computing music service, free VoIP, mobility and location based services and a suite of collaboration platforms. In this report, we explore the notion that Google is not just driving broadband but r …
- アメリカの神経診断・モニタリング装置市場2016-2020About Neurodiagnostic and Monitoring Devices Neurodiagnostic and monitoring devices are used to monitor and record electrical activity in the brain, muscles, spinal cord, and other nerves. These devices are primarily used for diagnosing chronic brain disorders, such as sleep disorders, brain tumors, epilepsy, brain dysfunction, head injuries, encephalitis, strokes, and dementia. Technavio’s analys …
- 視力ケアの世界市場2016-2020About the Vision Care Market Uncorrected refractive errors are the main cause of severe and moderate visual impairment, while eye conditions such as pink eye and cataracts (non-refractive errors) are the leading causes of blindness in middle- and low-income countries. The governments in many countries have introduced national programs and regulations to control and prevent visual impairment. Eye c …
- 自動車ヘッドガスケットの世界市場2015-2019About automotive head gaskets Head gaskets are a vital part of engines and perform the critical function of sealing the engine block to the cylinder head. They have undergone several changes in their design and material composition to cater to changing technological trends and adapt to evolving specifications. In internal combustion engines, a mixture of air and fuel is ignited by a spark plug, le …
- 除細動器の世界市場予測2017-2026：体外式除細動器、植込み型除細動器、CRT-D、手動体外式除細動器、自動体外式除細動器、ウェアラブル除細動器The global defibrillators market is expected to grow at a CAGR of 5.3% from 2016-2020 and CAGR of 5.1% from 2020-2026. The market is expected to grow at a CAGR of 5.2% from 2016 to 2026. The market is estimated at $9.84bn in 2016, $12.07bn in 2020, and $16.29bn in 2026. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this secto …
